SPDL1 and melanoma: Soluble PD-L1 may result from alternative variants of the PD-L1 transcripts and cytokine treatment with IFN-α, IFN-γ, or TNF-α has been shown to increase secretion of sPD-L1 as well as expression of cell surface PD-L1 in melanoma cell lines (30).